Activist Beretta Rebuts Ruger's Claims, Confirms Proxy Solicitation for Director Nominees
Summary
Activist investor Beretta Holding S.A. issued a statement refuting Sturm, Ruger & Co.'s recent accusations and reaffirmed its intent to solicit votes for its slate of director nominees in the ongoing proxy contest.
Key Events
-
Beretta Rebuts Ruger's Accusations
Activist investor Beretta Holding S.A. directly responded to Sturm, Ruger's March 9 press release, accusing the company of making "blatantly false and misleading statements" regarding Beretta's investment.
-
Confirms Proxy Solicitation
Beretta reiterated its intention to file a preliminary proxy statement and use a WHITE universal proxy card to solicit votes for its slate of director nominees at the 2026 annual meeting.
-
Ongoing Proxy Contest Escalates
This filing marks a continuation of the escalating public dispute between Beretta Holding and Sturm, Ruger & Co. management over board composition and company performance, following previous filings and news reports.
-
Significant Shareholder Stake
Beretta Holding beneficially owns 1,587,000 shares of common stock, representing a substantial stake in Sturm, Ruger & Co.
Analysis
This filing provides a direct response from activist investor Beretta Holding S.A. to Sturm, Ruger & Co.'s recent public statements, escalating the ongoing proxy contest. Beretta's rebuttal of management's "false and misleading statements" signals a continued contentious battle for board control. The explicit confirmation of their intent to file a preliminary proxy statement and use a WHITE universal proxy card indicates that Beretta is moving forward with its plan to elect its director nominees at the upcoming annual meeting. Investors should expect continued public exchanges and a contested shareholder vote, which could lead to significant changes in the company's strategic direction and governance.
At the time of this filing, RGR was trading at $38.96 on NYSE in the Manufacturing sector, with a market capitalization of approximately $621.2M. The 52-week trading range was $28.33 to $48.21. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.